Cancer Biology Graduate Interdisciplinary Program, The University of Arizona, Tucson, Arizona, United States of America.
School of Animal & Comparative Biomedical Sciences, The University of Arizona, Tucson, Arizona, United States of America.
PLoS Pathog. 2020 Nov 30;16(11):e1009028. doi: 10.1371/journal.ppat.1009028. eCollection 2020 Nov.
Oncogenic human papillomaviruses (HPVs) replicate in differentiating epithelium, causing 5% of cancers worldwide. Like most other DNA viruses, HPV infection initiates after trafficking viral genome (vDNA) to host cell nuclei. Cells possess innate surveillance pathways to detect microbial components or physiological stresses often associated with microbial infections. One of these pathways, cGAS/STING, induces IRF3-dependent antiviral interferon (IFN) responses upon detection of cytosolic DNA. Virion-associated vDNA can activate cGAS/STING during initial viral entry and uncoating/trafficking, and thus cGAS/STING is an obstacle to many DNA viruses. HPV has a unique vesicular trafficking pathway compared to many other DNA viruses. As the capsid uncoats within acidic endosomal compartments, minor capsid protein L2 protrudes across vesicular membranes to facilitate transport of vDNA to the Golgi. L2/vDNA resides within the Golgi lumen until G2/M, whereupon vesicular L2/vDNA traffics along spindle microtubules, tethering to chromosomes to access daughter cell nuclei. L2/vDNA-containing vesicles likely remain intact until G1, following nuclear envelope reformation. We hypothesize that this unique vesicular trafficking protects HPV from cGAS/STING surveillance. Here, we investigate cGAS/STING responses to HPV infection. DNA transfection resulted in acute cGAS/STING activation and downstream IFN responses. In contrast, HPV infection elicited minimal cGAS/STING and IFN responses. To determine the role of vesicular trafficking in cGAS/STING evasion, we forced premature viral penetration of vesicular membranes with membrane-perturbing cationic lipids. Such treatment renders a non-infectious trafficking-defective mutant HPV infectious, yet susceptible to cGAS/STING detection. Overall, HPV evades cGAS/STING by its unique subcellular trafficking, a property that may contribute to establishment of infection.
致癌性人乳头瘤病毒(HPV)在分化上皮细胞中复制,导致全球 5%的癌症。与大多数其他 DNA 病毒一样,HPV 感染是在病毒基因组(vDNA)运送到宿主细胞核后开始的。细胞具有先天的监测途径来检测微生物成分或与微生物感染相关的生理应激。这些途径之一,cGAS/STING,在检测到细胞质 DNA 时,诱导 IRF3 依赖性抗病毒干扰素(IFN)反应。病毒粒子相关的 vDNA 可以在初始病毒进入和脱壳/运输过程中激活 cGAS/STING,因此 cGAS/STING 是许多 DNA 病毒的障碍。与许多其他 DNA 病毒相比,HPV 具有独特的囊泡运输途径。当衣壳在酸性内体隔间中脱壳时,次要衣壳蛋白 L2 穿过囊泡膜突出,以促进 vDNA 向高尔基体的运输。L2/vDNA 存在于高尔基体腔中,直到 G2/M 期,此时囊泡 L2/vDNA 沿着纺锤体微管运输,与染色体结合以进入子细胞核。含有 L2/vDNA 的囊泡可能在核膜重建后直到 G1 期才保持完整。我们假设这种独特的囊泡运输方式保护 HPV 免受 cGAS/STING 的监测。在这里,我们研究了 cGAS/STING 对 HPV 感染的反应。DNA 转染导致急性 cGAS/STING 激活和下游 IFN 反应。相比之下,HPV 感染仅引起最小的 cGAS/STING 和 IFN 反应。为了确定囊泡运输在 cGAS/STING 逃避中的作用,我们用破坏膜的阳离子脂质强制穿透囊泡膜的病毒早期穿透。这种处理使一种无感染性的运输缺陷突变 HPV 感染,但易受 cGAS/STING 检测。总体而言,HPV 通过其独特的细胞内运输逃避 cGAS/STING,这一特性可能有助于建立感染。